Publications by the researcher in collaboration with Luis Martínez Martínez (63)

2023

  1. Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)

    Frontiers in Microbiology

  2. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370

  3. In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

  4. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

2022

  1. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  2. Justification for 24/7 clinical microbiology services

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software

    Frontiers in Microbiology, Vol. 12

2021

  1. Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 9

  2. Fundamentals and implementation of Microbiological Diagnostic Stewardship Programs

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 5, pp. 248-251

  3. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637

2020

  1. Activity of imipenem-relebactam against a large collection of pseudomonas aeruginosa clinical isolates and isogenic β-lactam-resistant mutants

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 2

  2. Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae

    Microbial Genomics, Vol. 6, Núm. 5, pp. 1-18

  3. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens

    Scientific Reports, Vol. 10, Núm. 1

  4. Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187

2019

  1. Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: Results from a Spanish nationwide survey

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 11, pp. 3217-3220

  2. Combined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii

    Microorganisms, Vol. 7, Núm. 11

  3. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 7, pp. 1825-1835

2018

  1. Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade

    Scientific Reports, Vol. 8, Núm. 1

  2. Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop

    Microbial Drug Resistance, Vol. 24, Núm. 5, pp. 527-533

  3. Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii

    Frontiers in Microbiology, Vol. 9